"Designing Growth Strategies is in our DNA"
Lung cancer or lung carcinoma is a malignant tumor caused by uncontrolled cell growth in the tissues of the lungs. Lung cancer is categorized into two types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Additionally, Non-small cell lung cancer is sub-segmented into squamous cell carcinoma, large cell undifferentiated carcinoma, and adenocarcinoma.
Several stages of lung cancer are treated by chemotherapy or radiation therapy and the surgical treatment for lungs cancer is done in rare cases during the reoccurrence of lung cancer and failure of chemotherapy. Lung cancer surgery is ablation of lungs or cancer affected lobe. According to the American Cancer Society, about 228,150 new cases of lung cancer are estimated in the U.S. in 2019.
To gain extensive insights into the market, Request for Customization
Increasing incidences of lung cancer due to change in lifestyle, smoking habits, genetic inheritance, and inhalation of carcinogenic substances are the factors driving the growth of the global lung cancer surgical treatment market. Lung cancer is the leading cause of cancer deaths worldwide is also responsible to drive the global lung cancer surgical treatment market owing to the rising demand for the prevention of cancer.
New surgical approaches like robotic surgery and other technological advancements such as minimally invasive surgical procedures are some of the factors expected to drive the growth of the global lung cancer surgical treatment market.
However, high treatment cost associated with surgeries and limited accessibility to new and advanced treatment techniques, especially in emerging countries are some the factors restraining the global lung cancer surgical treatment market.
Some of the key players present in the global lung cancer surgical treatment market are Covidien PLC, Ethicon US LLC, AngioDynamics Inc., Intuitive Surgical Inc., Accuray Inc., Teleflex Inc., Scanlan International Inc., Olympus Corporation, KARL STORZ GmbH, Ackermann Instrumente GmbH, Trokamed GmbH, and others.
By Surgical Procedure
· Sleeve Resection
· North America (the USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Among the segmentation, lobectomy in the surgical procedure segment accounts for larger market share and is anticipated to show a higher growth during the forecast period owing to its benefits, convenience, and effects even after the removal of the affected lobe from the lung.
Geographically, the global lung cancer surgical treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a significant market share due to the higher prevalence of lung cancer, adequate reimbursement policies, and advanced healthcare infrastructure leading to increased adoption of technologically advanced techniques such as robotic surgery for the treatment of lung cancer. The Asia Pacific is expected to be lucrative market owing to rapid development in the healthcare sector, increase in the awareness regarding new developments in the lung cancer treatment among healthcare providers, and increasing adoption of technologically advanced techniques in Japan and emerging countries such as India and China.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry